Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Allergic rhinitis (AR) impairs quality of life (QoL), sleep and work. The Allergic Rhinitis and its Impact on Asthma (ARIA) classification is widely used, but the impact of the different symptoms on QoL is not clear. Objective: To describe characteristics of patients consulting in primary care for AR and to study the impact of AR symptoms and the ARIA classes on QoL. Methods: A multicenter prospective observational cross-sectional study assessed the visual analogue scale (VAS) in the management of AR in 990 patients consulting general practitioners for AR. Patients were classified according to the four classes of ARIA. VAS, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and total symptom score (TSS) for nasal and non-nasal symptoms were evaluated. VAS and TSS measures were compared with RQLQ. Results: Mild intermittent rhinitis was diagnosed in 20% of patients, mild persistent rhinitis in 17%, moderate/severe intermittent rhinitis in 15% and moderate/severe persistent rhinitis in 48%. The presence of treatments did not affect VAS levels. Both severity and duration of rhinitis had an impact on QoL and VAS levels. Ocular symptoms (OR: 2.78, 95% CI: 1.965–3.939) including eyelid edema (OR: 2.07, 95% CI: 1.274–3.360) and asthenia (OR: 2.73, 95% CI: 1.922–3.877) had more impact on RQLQ than nasal obstruction (OR: 1.61, 95% CI: 1.078–2.405) and nasal pruritus (OR 1.45, 95% CI: 1.028–2.042). Sneezing and rhinorrhea did not impact RQLQ. Conclusions: This study confirmed that ocular symptoms and, to a lesser degree, nasal obstruction and pruritus have a significant impact on QoL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, extranasal symptoms, particularly ocular symptoms, have a significant impact on QOL and should not be ignored in the evaluation and management of AR.681-684”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [681]
In the citing paper
“However, other studies conducted in the primary care setting find little correlation between the intensity of NO measured by the symptoms scale and specific QOL questionnaires in AR (assessed using the Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ]) [87].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [87]
Citations
Cites
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationAllergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Self-citationDevelopment and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
JUNIPER, E. F., & GUYATT, G. H. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00807.x · Cited by 811
Bousquet, P. J., Combescure, C., Neukirch, F., Klossek, J. M., Méchin, H., Daures, J. ‐., & Bousquet, J. (2007) · Allergy · doi:10.1111/j.1398-9995.2006.01276.x · Cited by 418
Self-citationSeverity and impairment of allergic rhinitis in patients consulting in primary care
Bousquet, J., Neukirch, F., Bousquet, P. J., Gehano, P., Klossek, J. M., Le Gal, M., & Allaf, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.047 · Cited by 298
Self-citationCharacteristics of intermittent and persistent allergic rhinitis: DREAMS study group
Bousquet, J., Annesi‐Maesano, I., Carat, F., Léger, D., Rugina, M., Pribil, C., El Hasnaoui, A., & Chanal, I. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02274.x · Cited by 237
Self-citationPrevalence, classification and perception of allergic and nonallergic rhinitis in Belgium
Bachert, C., Van Cauwenberge, P., Olbrecht, J., & Van Schoor, J. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01054.x · Cited by 236
Validation of the classification of ARIA (allergic rhinitis and its impact on asthma)
Demoly, P., Allaert, F. ‐., Lecasble, M., Bousquet, J., & PRAGMA (2003) · Allergy · doi:10.1034/j.1398-9995.2003.t01-1-00202.x · Cited by 187
Self-citationImportant research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper
Bousquet, J., Fokkens, W., Burney, P., Durham, S. R., Bachert, C., Akdis, C. A., Canonica, G. W., Dahlen, S. ‐., Zuberbier, T., Bieber, T., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01715.x · Cited by 178
Self-citationImplementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial
Bousquet, J., Lund, V. J., Van Cauwenberge, P., Bremard‐Oury, C., Mounedji, N., Stevens, M. T., & El‐Akkad, T. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00076.x · Cited by 171
Self-citation
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Klimek, L., Bergmann, K.-C., Biedermann, T., Bousquet, J., Hellings, P., Jung, K., Merk, H., Olze, H., Schlenter, W., Stock, P., et al. (2017) · Allergo Journal International · doi:10.1007/s40629-016-0006-7 · Cited by 475
Self-citationBirch Pollen Allergy in Europe
Biedermann, T., Winther, L., Till, S. J., Panzner, P., Knulst, A., & Valovirta, E. (2019) · Allergy · doi:10.1111/all.13758 · Cited by 310
Meltzer, E. O. (2016) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2015.12.002 · Cited by 293
Bousquet, J., Schunemann, H. J., Fonseca, J., Samolinski, B., Bachert, C., Canonica, G. W., Casale, T., Cruz, A. A., Demoly, P., Hellings, P., et al. (2015) · Allergy · doi:10.1111/all.12686 · Cited by 201
Self-citation2019 ARIA Care pathways for allergen immunotherapy
Bousquet, J., Pfaar, O., Togias, A., Schünemann, H. J., Ansotegui, I., Papadopoulos, N. G., Tsiligianni, I., Agache, I., Anto, J. M., Bachert, C., et al. (2019) · Allergy · doi:10.1111/all.13805 · Cited by 185
Self-citationAllergic rhinitis: diagnosis and management
Siddiqui, Z., Walker, A., Pirwani, M., Tahiri, M., & Syed, I. (2022) · British Journal of Hospital Medicine · doi:10.12968/hmed.2021.0570 · Cited by 176
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
Bousquet, J., Schünemann, H. J., Hellings, P. W., Arnavielhe, S., Bachert, C., Bedbrook, A., Bergmann, K.-C., Bosnic-Anticevich, S., Brozek, J., Calderon, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.03.025 · Cited by 168
“56 Patients want more effective treatments that can control all their symptoms, including ocular ones, 61,62 and a more rapid onset of action.”
Self-citationBousquet, J., Hellings, P. W., Agache, I., Bedbrook, A., Bachert, C., Bergmann, K. C., Bewick, M., Bindslev-Jensen, C., Bosnic-Anticevitch, S., Bucca, C., et al. (2016) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0137-4 · Cited by 160
Self-citationBurden of allergic respiratory disease: a systematic review
Linneberg, A., Dam Petersen, K., Hahn-Pedersen, J., Hammerby, E., Serup-Hansen, N., & Boxall, N. (2016) · Clinical and Molecular Allergy · doi:10.1186/s12948-016-0049-9 · Cited by 151
Liu, J., Zhang, X., Zhao, Y., & Wang, Y. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228533 · Cited by 181
Bousquet, J. J., Devillier, P., Arnavielhe, S., Bedbrook, A., Alexis‐Alexandre, G., van Hague, M., Murray, R., Canonica, G. W., Illario, M., Menditto, E., et al. (2018) · Allergy · doi:10.1111/all.13406 · Cited by 139
“5]) similar to FF monotherapy (15 [0-39]) and MF monotherapy (17 [8-32]), but significantly lower than FF + OAH (31 [14-58]) or MF + OAH 34 (16-58).”
BackgroundInfluentialSelf-citationMeltzer, E., Ratner, P., Bachert, C., Carr, W., Berger, W., Canonica, G. W., Hadley, J., Lieberman, P., Hampel, F. C., Mullol, J., et al. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000351404 · Cited by 116
Self-citationAllergen Immunotherapy (AIT): a prototype of Precision Medicine
Canonica, G., Bachert, C., Hellings, P., Ryan, D., Valovirta, E., Wickman, M., De Beaumont, O., & Bousquet, J. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0079-7 · Cited by 114
Self-citationBousquet, J. J., Caimmi, D. P., Bedbrook, A., Bewick, M., Hellings, P. W., Devillier, P., Arnavielhe, S., Bachert, C., Bergmann, K., Canonica, G. W., et al. (2017) · Allergy · doi:10.1111/all.13125 · Cited by 123
“Although ocular symptoms are the most bothersome symptoms of AR (34, 35), their relationship with work has not Table 3 Reporting of asthma”
BackgroundSelf-citationThe hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey
Price, D., Scadding, G., Ryan, D., Bachert, C., Canonica, G. W., Mullol, J., Klimek, L., Pitman, R., Acaster, S., Murray, R., et al. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-015-0083-6 · Cited by 105
“Fortunately, the burden of AR is now being recognised both by the European Academy of Allergy & Clinical Immunology (EAACI) as well as at the EU parliament level, in order to highlight the profound impact this prevalent condition has on the quality of life (QoL) of AR sufferers and their families [8, 9].”
BackgroundResultInfluentialSelf-citationBjermer, L. H., Westman, M., Holmström, M., & Wickman, M. C. (2019) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0314-1 · Cited by 131
Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS
Courbis, A.-L., Murray, R., Arnavielhe, S., Caimmi, D. P., Bedbrook, A., Eerd, M. V., de Vries, G., Dray, G., Agache, I. O., Morais‐Almeida, M., et al. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13230 · Cited by 87
Self-citationDaily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study
Bousquet, J. J., Devillier, P., Anto, J. M., Bewick, M., Haahtela, T., Arnavielhe, S., Bedbrook, A., Murray, R., Eerd, M. V., Fonseca, J., et al. (2018) · Allergy · doi:10.1111/all.13448 · Cited by 94
“90-99 409 91 (79-96) 78 (45-94) 54 (5-92) N = 213 69 (52-85)”
InfluentialSelf-citationA circadian based inflammatory response – implications for respiratory disease and treatment
Comas, M., Gordon, C. J., Oliver, B. G. G., Stow, N. W., King, G. G., Sharma, P. K., Ammit, A. J., Grunstein, R. R., & Phillips, C. L. (2017) · Sleep Science and Practice · doi:10.1186/s41606-017-0019-2 · Cited by 84
Position Paper on Nasal Obstruction: Evaluation and Treatment
SEAIC Rhinoconjunctivitis Committee & SEORL Rhinology, A., Valero, A., Navarro, A., del Cuvillo, A., Alobid, I., Benito, Jr., Colás, C., de los Santos, G., Fernández Liesa, R., García-Lliberós, A., et al. (2018) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0232 · Cited by 76
Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews
Nurmatov, U. B., Dhami, S., Arasi, S., Roberts, G. C., Pfaar, O., Muraro, A. M., Ansotegui, I. J., Calderón, M. A., Cingi, C., Durham, S. R., et al. (2017) · Clinical and Translational Allergy · doi:10.1186/s13601-017-0159-6 · Cited by 79
Burte, E., Leynaert, B., Marcon, A., Bousquet, J. J., Benmerad, M., Bono, R., Carsin, A., de Hoogh, K., Forsberg, B., Gormand, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.040 · Cited by 78
Self-citationWang, K., Wang, C., Xi, L., Zhang, Y., Ouyang, Y., Lou, H., Zhang, W., & Zhang, L. (2014) · International Archives of Allergy and Immunology · doi:10.1159/000356317 · Cited by 62
Klimek, L., Bachert, C., Mösges, R., Munzel, U., Price, D., Virchow, J. C., Wahn, U., & Bousquet, J. (2015) · Allergy and Asthma Proceedings · doi:10.2500/aap.2015.36.3823 · Cited by 58
Self-citationBSACI guideline for the diagnosis and management of pollen food syndrome in the UK
Skypala, I. J., Hunter, H., Krishna, M. T., Rey‐Garcia, H., Till, S. J., du Toit, G., Angier, E., Baker, S., Stoenchev, K. V., & Luyt, D. K. (2022) · Clinical & Experimental Allergy · doi:10.1111/cea.14208 · Cited by 57
Devillier, P., Bousquet, J. J., Salvator, H., Naline, E., Grassin‐Delyle, S., & de Beaumont, O. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12801 · Cited by 59
Self-citationdel Cuvillo, A., Santos, V., Montoro, J., Bartra, J., Davila, I. J., Ferrer, M., Jáurequi, I., Sastre, J., Mullol, J., & Valero, A. (2017) · Rhinology Journal · doi:10.4193/rhin16.025 · Cited by 53
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Vieira, R. J., Pham‐Thi, N., Antó, J. M., Czarlewski, W., Sá‐Sousa, A., Amaral, R., Bedbrook, A., Bosnic-Anticevich, S. Z., Brussino, L., Canonica, G. W., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.08.015 · Cited by 59
Self-citationCanonica, G. W., Triggiani, M., & Senna, G. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0029-5 · Cited by 50
“Currently considered first-line therapies (even multiple therapies) do not consistently offer optimal symptomatic relief for many AR patients [17, 18].”
Wang, J., Xue Kang, M., Huang, Z., Li Shen, M., Luo, Q., Li, M., Luo, L., Tu, J., Han, M., & Ye, J. (2020) · American Journal of Rhinology and Allergy · doi:10.1177/1945892420932486 · Cited by 47
Roger, A., Campillo, E. A., Torres, M. C., Millan, C., Jauregui, I., Mohedano, E., Liñán, S., Verdu, P., Rubira, N., Santaolalla, M., et al. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0146-9 · Cited by 54
“The data are in accord with the existing reports of the impairment of work/academic productivity [3, 4, 6] and HRQOL [7, 8] by AR in other countries.”
BackgroundResultSiroux, V., Boudier, A., Nadif, R., Lupinek, C., Valenta, R., & Bousquet, J. (2018) · Allergy · doi:10.1111/all.13676 · Cited by 45
“In fact, ocular symptoms are among the most bothering symptoms of allergic rhinoconjunctivitis.(1,2) However, the links between nasal and ocular symptoms are unclear.”
BackgroundSelf-citationYin, Z., Geng, G., Xu, G., Zhao, L., & Liang, F. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00389-9 · Cited by 53
“The condition is manifested by sudden and recurrent nasal congestion, itchiness, sneezing, and runny nose [3].”
BackgroundDoes evidence support the use of cat allergen immunotherapy?
Dhami, S., & Agarwal, A. (2018) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0000000000000457 · Cited by 44
Comparison of outcome measures in allergic rhinitis in children, adolescents and adults
Devillier, P., Bousquet, P., Grassin‐Delyle, S., Salvator, H., Demoly, P., Bousquet, J., & de Beaumont, O. (2016) · Pediatric Allergy and Immunology · doi:10.1111/pai.12561 · Cited by 43
“Rhinorrhoea and sneezing were not associated with poor QoL in any of the three groups, as also recently reported in adults (15).”
ResultSelf-citationHusain, Q. M., Hoehle, L. P., Phillips, K. M., Caradonna, D. S., Gray, S. T., & Sedaghat, A. R. (2019) · American Journal of Rhinology and Allergy · doi:10.1177/1945892419884789 · Cited by 47
Current recommendations and emerging options for the treatment of allergic rhinitis
Licari, A., Ciprandi, G., Marseglia, A., Castagnoli, R., Barberi, S., Caimmi, S. M. E., & Marseglia, G. L. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.955476 · Cited by 43
“Many of these issues are related to poor sleep quality and sleep disturbances caused by AR [10].”
BackgroundIntranasal Spray Medications for Maintenance Therapy of Allergic Rhinitis
Berger, W. E., & Meltzer, E. O. (2015) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2015.29.4215 · Cited by 40
Sleep disorders in children with moderate to severe persistent allergic rhinitis
Loekmanwidjaja, J., Carneiro, A. C. F., Nishinaka, M. L. T., Munhoes, D. A., Benezoli, G., Wandalsen, G. F., & Solé, D. (2017) · Brazilian Journal of Otorhinolaryngology · doi:10.1016/j.bjorl.2017.01.008 · Cited by 42
Allergic and non-allergic rhinitis: relationship with nasal polyposis, asthma and family history.
Gelardi, M., Iannuzzi, L., Tafuri, S., Passalacqua, G., & Quaranta, N. A. A. (2014) · PubMed Central · Cited by 51
Systematic review of measures of disease severity in rhinitis
Li, A. R., Zhang, K., Reddy, P. D., Nguyen, S. A., Miglani, A., Fried, J., Nguyen, M. I., & Schlosser, R. J. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22794 · Cited by 40
Current controversies and challenges in allergic rhinitis management
Price, D. B., Smith, P. K., Hellings, P. W., Papadopoulos, N. G., Fokkens, W. J., Muraro, A. M., Murray, R., Chisholm, A., Demoly, P. M., Scadding, G. K., et al. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.1081814 · Cited by 39
“Despite multiple therapy usage, these patients reported significant residual nasal and ocular symptoms, a finding which has been replicated in other studies [37] and confirmed in the literature [38,39].”
ResultSelf-citationMonitoring Allergen Immunotherapy Effects by Microarray
Lupinek, C., Wollmann, E., & Valenta, R. (2016) · Current Treatment Options in Allergy · doi:10.1007/s40521-016-0084-2 · Cited by 36
Hisinger‐Mölkänen, H., Piirilä, P. L., Haahtela, T., Sovijärvi, A. R. A., & Pallasaho, P. (2018) · World Allergy Organization Journal · doi:10.1186/s40413-018-0184-5 · Cited by 35
Bousquet, J. J., Bachert, C., Bernstein, J., Canonica, G. W., Carr, W., Dahl, R., Demoly, P. M., Devillier, P., Hellings, P. W., Fokkens, W. J., et al. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1020789 · Cited by 35
“Increased disease complexity has been accompanied by increased treatment regimen complexity, with high multiple therapy usage reported in surveys conducted in Europe [8,9,11-13].”
BackgroundInfluentialSelf-citationManaging Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
Lourenço, O. M., Bosnic-Anticevich, S. Z., Costa, E. M., Fonseca, J., Menditto, E., Cvetkovski, B., Kritikos, V. S., Tan, R. H., Bedbrook, A., Scheire, S., et al. (2020) · Pharmacy · doi:10.3390/pharmacy8020085 · Cited by 40
“A VAS for ocular symptoms may also be used and can complement the VAS for nasal symptoms [53].”
MethodSelf-citationClinical Relevance of Cluster Analysis in Phenotyping Allergic Rhinitis in a Real-Life Study
Bousquet, P., Devillier, P., Tadmouri, A., Mesbah, K., Demoly, P. M., & Bousquet, J. J. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000381339 · Cited by 41
Self-citationNovakova, S. M., Staevska, M. T., Novakova, P. I., Yoncheva, M. D., Bratoycheva, M. S., Мусурлиева, Н., Tzekov, V., & Nicolov, D. G. (2017) · Health and Quality of Life Outcomes · doi:10.1186/s12955-017-0764-z · Cited by 36
“Eye symptom is the aspect that, together with nasal symptoms, congestion in particular, has been found to strongly affect HRQoL [23, 26].”
BackgroundVandenplas, O., Suarthana, E., Rifflart, C., Lemière, C., Moual, N. L., & Bousquet, J. J. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.12.033 · Cited by 35
Self-citationZhou, S., Hur, K., Shen, J., & Wrobel, B. (2017) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.87 · Cited by 35
Ambient pollen exposure and pollen allergy symptom severity in the EPOCHAL study
Luyten, A., Bürgler, A., Glick, S., Kwiatkowski, M., Gehrig, R., Beigi, M., Hartmann, K., & Eeftens, M. (2024) · Allergy · doi:10.1111/all.16130 · Cited by 33
Katotomichelakis, M., Nikolaidis, C., Makris, M. P., Zhang, N., Aggelidis, X., Constantinidis, T. C., Bachert, C., & Danielides, V. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21623 · Cited by 30
Tongtako, W., Klaewsongkram, J., Mickleborough, T. D., & Suksom, D. (2018) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-040417-0066 · Cited by 31
Wei, C. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.003 · Cited by 31
Spatiotemporal monitoring of allergic rhinitis symptoms in the Netherlands using citizen science
de Weger, L. A., Hiemstra, P. S., den Buysch, E. O., & van Vliet, A. J. H. (2014) · Allergy · doi:10.1111/all.12433 · Cited by 27
“Their self-reports indicate that the majority have been tested positively for grass (71%) and/or birch pollen (72), which is in line with results from a multicenter French study (16).”
ResultManagement of allergic rhinitis in the era of effective over-the-counter treatments
Carr, W., & Yawn, B. P. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1333384 · Cited by 28
Sublingual allergen immunotherapy for respiratory allergy: a systematic review
Blanco, C., Bazire, R., Argíz, L., & Hernández-Peña, J. (2018) · Drugs in Context · doi:10.7573/dic.212552 · Cited by 26
Lipworth, B. J., Newton, J., Ram, B., Small, I. R., & Schwarze, J. (2017) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-016-0001-y · Cited by 32
Hellings, P. W., Muraro, A. M., Fokkens, W. J., Mullol, J., Bachert, C., Canonica, G. W., Price, D. B., Papadopoulos, N. G., Scadding, G. K., Rasp, G., et al. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-015-0080-9 · Cited by 27
“The VAS has also been used to assess effectiveness of treatments in real-life [18] as well as inadequacies of others (including multiple treatments) [19].”
MethodSelf-citationAnti-allergic effects of vitamin E in allergic diseases: An updated review
Shams, M. H., Jafari, R., Eskandari, N., Masjedi, M., Kheirandish, F., Ganjalıkhani-Hakemi, M., Ghasemi, R., Varzi, A. M., Sohrabi, S. M., Baharvand, P. A., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107196 · Cited by 26
Li, X., Wu, H., Xing, W., Xia, W., Jia, P., Yuan, K., Guo, F., Ran, J., Wang, X., Ren, Y., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108319 · Cited by 24
Prenner, B. M. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s98172 · Cited by 24
Price, D. B., Scadding, G. K., Bachert, C., Saleh, H. A., Nasser, S. M., Carter, V. A., von Ziegenweidt, J., Durieux, A. M. S., & Ryan, D. P. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2016.33 · Cited by 25
“Ocular symptoms are common, difficult to control and have the greatest negative impact on patients’ quality of life.(10,11) AR symptoms impair patients’ function in day-to-day life,(4,12,13) and cause sleep disturbance,(14) fatigue, absenteeism and productivity loss at work and school (presenteeism).”
BackgroundResultZhang, J., Zhang, Y., Huang, X., Lan, K., Hu, L., Chen, Y., & Yu, H. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/8363027 · Cited by 26
Renal function curves and control of body fluids and arterial pressure.
Guyton, A. C. (1990) · PubMed · Cited by 35
Treatment history and association between allergic rhinitis symptoms and quality of life
Speth, M. M., Hoehle, L. P., Phillips, K. M., Caradonna, D. S., Gray, S. T., & Sedaghat, A. R. (2018) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-018-1866-2 · Cited by 25
Lin, K., Huang, W., Lin, C.-C., Jen, Y., Lin, C., Lo, C., & Kao, C. (2014) · Head & Neck · doi:10.1002/hed.23617 · Cited by 22
“Allergic rhinitis is also associated with a lower quality of life.(5,6) The prevalence of allergic rhinitis varies worldwide.”
BackgroundObjectifying the Conjunctival Provocation Test: Photography-Based Rating and Digital Analysis
Doğan, S., Astvatsatourov, A., Deserno, T. M., Bock, F., Shah‐Hosseini, K., Michels, A., & Mösges, R. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000355333 · Cited by 20
Rhinologic disease and its impact on sleep: a systematic review
Fried, J., Yuen, E., Li, A. R., Zhang, K., Nguyen, S. A., Gudis, D. A., Rowan, N. R., & Schlosser, R. J. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22740 · Cited by 21
MP29-02: a breakthrough for the treatment of allergic rhinitis
Bernstein, J. A. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.828693 · Cited by 16
“By the time they present to an allergy specialist, many patients have tried multiple therapeutic regimens [1,2,12-16].”
BackgroundProbiotics as adjuvant therapy in the treatment of Allergic Rhinitis.
Mancin, S., & Mazzoleni, B. (2023) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2023.00394 · Cited by 20
Ilyina, N. I., Edin, A., Astafieva, N. G., As, L., Sidorenko, I. V., Ukhanova, O. P., & Khanova, F. (2019) · International Archives of Allergy and Immunology · doi:10.1159/000494507 · Cited by 20
Braido, F., Baiardini, I., Scichilone, N., Musarra, A., Menoni, S., Ridolo, E., Gani, F., Pravettoni, V., Colombo, G., Crivellaro, M., et al. (2014) · Rhinology Journal · doi:10.4193/rhino13.040 · Cited by 24
Allergen immunotherapy for allergic rhinoconjunctivitis: protocol for a systematic review
Dhami, S., Nurmatov, U. B., Roberts, G. C., Pfaar, O., Muraro, A. M., Ansotegui, I. J., Calderón, M. A., Cingi, C., Demoly, P. M., Durham, S. R., et al. (2016) · Clinical and Translational Allergy · doi:10.1186/s13601-016-0099-6 · Cited by 17
Self-citationKolek, F., Plaza, M. P., Charalampopoulos, A. F., Traidl‐Hoffmann, C., & Damialis, A. (2021) · Atmospheric Environment · doi:10.1016/j.atmosenv.2021.118774 · Cited by 20
Allergic rhinitis and risk of systemic lupus erythematosus: A systematic review and meta‐analysis
Wongtrakul, W., Charoenngam, N., Ponvilawan, B., & Ungprasert, P. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13928 · Cited by 17
Catching allergy by a simple questionnaire
Galimberti, M., Passalacqua, G., Incorvaia, C., Castella, V., Costantino, M. T., Cucchi, B., Gangemi, S., Nardi, G., Raviolo, P., Rottoli, P., et al. (2015) · World Allergy Organization Journal · doi:10.1186/s40413-015-0067-y · Cited by 18
“Its impact on the quality of life, also due to the numerous comorbidities (including asthma, sleep disturbances, otitis, rhinosinusitis) is recognized on scientific bases [13-15] and is well known to allergy specialists.”
BackgroundChanges of T-helper type 1/2 cell balance by anticholinergic treatment in allergic mice
Daoud, A., Xie, Z., Yanhong, M. A., Wang, T., & Tan, G. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.12.014 · Cited by 17
Rodrigues, J., Rocha, M. I., Teixeira, F., de Resende, B. E., Cardoso, A., Sá, S. I., Vaz, R., & Raemdonck, K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114171 · Cited by 17
Katotomichelakis, M., Riga, M. G., Tripsianis, G., Balatsouras, D. G., Kourousis, C., Danielides, G., Giotakis, E. I., & Danielides, V. (2014) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489414565001 · Cited by 18
“Although allergic rhinitis (AR) does not represent a lifethreatening condition, it is usually the cause of evident deterioration in patients’ quality of life (QoL).(1-4) To date, it is recognized that in addition to symptom improvement, the patients’ perceptions also play a significant role for an objective evaluation…”
BackgroundInfluentialCharacteristics and predictors of allergic rhinitis undertreatment in primary care
Spinozzi, F., Murgia, N., Baldacci, S., Maio, S., Pala, A. P., Casciari, C., Dell’Omo, M., Viegi, G., & on behalf of ARGA study group (2015) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632015595779 · Cited by 19
Karaulov, A. V., Nenasheva, N. M., Smolkin, Y. S., Сергеевич, М. А., & Lucio, L. A. G. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000518753 · Cited by 15
Derendorf, H., Meltzer, E. O., Hermann, R., & Canonica, G. W. (2014) · Drugs of today · doi:10.1358/dot.2014.50.1.2094806 · Cited by 16
Katotomichelakis, M., Danielides, G., Iliou, T., Anastassopoulos, G. C., Nikolaidis, C., Kyrodimos, E., Giotakis, E. I., & Constantinidis, T. C. (2016) · International Journal of Pediatric Otorhinolaryngology · doi:10.1016/j.ijporl.2016.07.027 · Cited by 20
Quality of life in adult patients using dialyzable leukocyte extract for allergic rhinitis
Homberg, T. A., Lara, I., Andaluz, C., Cervantes-Trujano, E., Hernández-Martínez, P. M., Pérez‐Tapia, S. M., & Martínez, M. D. C. J. (2023) · Medicine · doi:10.1097/md.0000000000034186 · Cited by 14
“Bousquet et al[31] found that ocular symptoms had the highest impact on QoL, followed by nasal obstruction and pruritus, to a lesser degree.”
BackgroundKritikos, V. S., Price, D. B., Papi, A. A., Infantino, A., Ställberg, B., Ryan, D. P., Lavorini, F., Chrystyn, H., Haughney, J., Lisspers, K., et al. (2020) · Journal of Asthma and Allergy · doi:10.2147/jaa.s266204 · Cited by 15
Mikkelsen, S., Dinh, K. M., Boldsen, J. K., Pedersen, O. B., Holst, G. J., Petersen, M. S., Kaspersen, K. A., Møller, B. K., Nielsen, K. R., Paarup, H. M., et al. (2021) · Clinical and Translational Allergy · doi:10.1002/clt2.12013 · Cited by 14
Yung, T. Y., Zhang, H., Tang, L. C., Zhang, L., Law, C. O., Tam, W. M., Chan, C. W., Chen, H. C., Lee, M. H., Ziea, E. T.-C., et al. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0272-7 · Cited by 19
Primary Non-Adherence to Antihistamines—Conclusions From E-Prescription Pilot Data in Poland
Kardas, G., Panek, M., Kuna, P., Cieszyński, J., & Kardas, P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00783 · Cited by 12
“Although the disease is not life-threatening, the associated troublesome symptoms adversely affect patients quality of life and their work effectiveness (Bousquet et al., 2013).”
BackgroundSymptomatology Patterns in Children with Allergic Rhinitis
Katotomichelakis, M., Iliou, T., Karvelis, I., Giotakis, E. I., Daniilides, G., Erkotidou, E., Lazaridis, C., & Anastassopoulos, G. C. (2017) · Medical Science Monitor · doi:10.12659/msm.903136 · Cited by 16
“Many studies have shown that AR symptoms are bothersome and impair patient psychosocial wellbeing and quality of life (QoL) [2,9,10], and furthermore cause a considerable socioeconomic cost [1,11,12].”
BackgroundAgache, I. O., Doros, I. C., Leru, P. M., Bucur, I. J., Poenaru, M., & Sarafoleanu, C. (2017) · Rhinology Journal · doi:10.4193/rhin16.278 · Cited by 15
“Nasal congestion was reported as the most bothersome nasal symptom, in agreement with other studies ((29)), and over 60% of patients complained of ocular symptoms, thought to have the greatest negative impact on patients’ QoL ((6)).”
BackgroundResultInfluentialKaulsay, R., Nguyen, D. T., & Kuhl, H. C. (2018) · Immunity Inflammation and Disease · doi:10.1002/iid3.237 · Cited by 15
Dai, L., Zhong, L. L. D., Kun, W., Lam, W. C., Yang, Z., Huang, T., Mu, H., & Bian, Z. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/6369754 · Cited by 14
2019 ARIA Care pathways for allergen immunotherapy
Bousquet, J. J., Pfaar, O., Togias, A. G., Schünemann, H. J., Ansotegui, I. J., Papadopoulos, N. G., Tsiligianni, I., Agache, I. O., Antó, J. M., Bachert, C., et al. (2019) · Alergologia · doi:10.26416/aler.3.4.2019.2749 · Cited by 13
Self-citationCuesta‐Herranz, J., Laguna, J. J., Mielgo, R., Pérez-Camo, I., Callejo, A. M., Begoña, L., Madariaga, B., Gómez, M., & Martinez, A. (2019) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.104 · Cited by 16
“Although AR does not endanger patients’ lives, it can result in considerable morbidity (6,7), and can cause a significant deterioration in patients’ quality of life (QoL) (8,9).”
BackgroundGálffy, G., Emmeluth, M., Koltun, A., Kopietz, F., Nguyen, D. T., & Kuhl, H. C. (2021) · Journal of Asthma and Allergy · doi:10.2147/jaa.s291747 · Cited by 13
“The use of 50 mm as a cut-off in this survey for assessing patients with uncontrolled disease is supported by the same VAS score used to indicate moderate to severe AR in previous studies.(10,11) Current 2019 ARIA guidelines recommend the following treatments: step 1 – nonsedating H1-antihistamine (oral, intranasal, o…”
BackgroundMethodKlimek, L., Bergmann, K.-C., Biedermann, T., Bousquet, J., Hellings, P., Jung, K., Merk, H., Olze, H., Schlenter, W., Stock, P., et al. (2017) · Allergo Journal · doi:10.1007/s15007-016-1228-1 · Cited by 12
“Ein VAS von 50 (auf einer 100-Millimeter-Skala) zeigt in den meisten Studien eine mäßiggradige bis starke AR an [45, 46, 47].”
BackgroundSelf-citationKlimek, L., Bousquet, J. J., & Price, D. B. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1122755 · Cited by 14
Self-citation
Metadata
- Authors
- Bousquet, P. J., Demoly, P., Devillier, P., Mesbah, K., & Bousquet, J.
- Affiliations
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- MSD (France) (FR)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2012-11-23
- Volume
- 160
- Issue
- 4
- Pages
- 393-400
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2046440947
- Cited by
- 204
- References
- 37
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 22 · 2019: 17 · 2018: 20 · 2017: 17 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 7
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- allergic rhinitis, quality of life, ARIA classification, Rhinoconjunctivitis Quality of Life Questionnaire, ocular symptoms, eyelid swelling, asthenia, nasal obstruction, nasal pruritus, sneezing, rhinorrhea, persistent rhinitis, primary care patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Asthma, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pain Measurement, Primary Health Care, Prospective Studies, Quality of Life, Surveys and Questionnaires, Rhinitis, Allergic, Perennial, Severity of Illness Index, Nasal Obstruction, Young Adult, Rhinitis, Allergic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.